1Steiner G. The dyslipoproteinemias of diabetes.Atherosclerosis 1994, 110(Suppl. )S27.
2Stamler J, Vassaro O, Neaton JD, et al. Diabetes, other risk factors and 12 - year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care1993, 16:434.
3Niskanen L, Turpeinen A, Uusitupa MI, et al. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovasoular mortality in type 2 diabetes: a 15 -year follow- up form the time of diagnosis. Diabetes Care 1998, 21:1861.
4Tkac I. Kimball BP. Lewis G. et al. The severity of coronary atherosclerosis in type 2 diabetes mellitus is related ti the number of circulating triglyceride - rich lipoprotein particles. Trteriosclerosis, Thrombosis & Vascular Biology 1997, 17:3633～3638.
6Kashiwazaki K, Hirano T, Yoshina G, et al. Decreased release of lipoprotein lipase is associated with vascular endothelial damage in NIDDM patients with microalbuminuria. Diabetes Care1998, 21:2016.
8[2]Report of a World Health Organization consultation on obesity[M].Geneva:WHO,1998.7-16
9[1]Meigs JB,Nathan DM,D' Agostino RB St,et al.Fasting and postchallenge glycemia and cardiovascular disease risk:the Framingham Offspring Study[J].Diabetes Care,2002,25 (10):1845-1850.
10[2]Qiao Q,Jousilahti P,Eriksson J,et al.Predictive properties of impaired glucose tolerance for cardiovascular risk are not explained by the development of overt diabetes during follow-up[J].Diabetes Care,2003,26 (10):2910-2914.
